PET imaging has shown that the binding levels of SERT in the brains of clinically advanced, non-depressed PD patients are significantly reduced in multiple brain regions, indicating that serotonergic neuron damage may be a common feature in advanced PD [182]. The gene discussed is SLC6A4; the disease is Parkinson disease.